Compugen Valuation
| CGEN Stock | USD 1.67 0.08 5.03% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Compugen shows a prevailing Real Value of $2.66 per share. The current price of the firm is $1.67. Our model approximates the value of Compugen from analyzing the firm fundamentals such as Shares Outstanding of 93.54 M, operating margin of (4.17) %, and Return On Equity of -0.53 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Compugen's valuation include:
Price Book 3.7456 | Enterprise Value | Enterprise Value Ebitda (19.16) | Price Sales 22.773 | Enterprise Value Revenue 11.8605 |
Undervalued
Today
Please note that Compugen's price fluctuation is very risky at this time. Calculation of the real value of Compugen is based on 3 months time horizon. Increasing Compugen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Compugen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Compugen Stock. However, Compugen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.67 | Real 2.66 | Target 5.8 | Hype 1.66 |
The intrinsic value of Compugen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Compugen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Compugen helps investors to forecast how Compugen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Compugen more accurately as focusing exclusively on Compugen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Compugen's intrinsic value based on its ongoing forecasts of Compugen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Compugen's closest peers.
Compugen Cash |
|
Compugen Total Value Analysis
Compugen is currently forecasted to have valuation of 81.87 M with market capitalization of 157.2 M, debt of 2.91 M, and cash on hands of 88.21 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Compugen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
81.87 M | 157.2 M | 2.91 M | 88.21 M |
Compugen Investor Information
About 14.0% of the company shares are held by institutions such as insurance companies. The book value of Compugen was currently reported as 0.47. The company recorded a loss per share of 0.3. Compugen had not issued any dividends in recent years. Based on the analysis of Compugen's profitability, liquidity, and operating efficiency, Compugen may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Compugen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Compugen has an asset utilization ratio of 24.23 percent. This suggests that the Company is making $0.24 for each dollar of assets. An increasing asset utilization means that Compugen is more efficient with each dollar of assets it utilizes for everyday operations.Compugen Profitability Analysis
Considering Compugen's profitability and operating efficiency indicators, Compugen may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Compugen's ability to earn profits and add value for shareholders.Net Loss | First Reported 2000-03-31 | Previous Quarter -7.3 M | Current Value -7 M | Quarterly Volatility 3.2 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.87 | 0.82 |
|
|
For Compugen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Compugen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Compugen utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Compugen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Compugen over time as well as its relative position and ranking within its peers.
Compugen Earnings per Share Projection vs Actual
By analyzing Compugen's earnings estimates, investors can diagnose different trends across Compugen's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Compugen is based on EPS before non-recurring items and includes expenses related to employee stock options.Compugen Ownership Allocation
Compugen holds a total of 93.54 Million outstanding shares. Almost 84.46 percent of Compugen outstanding shares are held by general public with 2.02 (percent) owned by insiders and only 13.52 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Compugen Profitability Analysis
The company reported the previous year's revenue of 27.86 M. Net Loss for the year was (14.23 M) with profit before overhead, payroll, taxes, and interest of 513 K.About Compugen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Compugen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Compugen based exclusively on its fundamental and basic technical indicators. By analyzing Compugen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Compugen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Compugen. We calculate exposure to Compugen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Compugen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 22.9 M | 24.1 M | |
| Pretax Profit Margin | (0.31) | (0.33) | |
| Operating Profit Margin | (0.48) | (0.51) | |
| Net Loss | (0.46) | (0.48) | |
| Gross Profit Margin | 0.82 | 0.87 |
Compugen Current Valuation Indicators
Compugen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Compugen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Compugen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Compugen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Compugen's worth.When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.30) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets | Return On Equity |
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.